General Announcement::iX Biopharma Reports Positive Results From Multi-Dose Wafermine Clinical Trial
Issuer & Securities
Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No
Announcement Details
Announcement Title
General Announcement
Date &Time of Broadcast
07-Mar-2016 17:39:23
Status
New
Announcement Sub Title
iX Biopharma Reports Positive Results From Multi-Dose Wafermine Clinical Trial
Announcement Reference
SG160307OTHR04SQ
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachments.
Attachments
iX Biopharma Reports Results from Multi-Dose Wafermine 2c Clinical Study.pdf
Report on Preliminary Results from Study KET-009.pdf
Total size =405K
Related Announcements
Related Announcements